Literature DB >> 19285288

The lay public's explicit and implicit definitions of drugs.

Ingunn Björnsdóttir1, Anna Birna Almarsdóttir, Janine Morgall Traulsen.   

Abstract

BACKGROUND: The research project: Public Beliefs about Medicine was initiated in 2001, aiming at exploring people's views, hopes, and fears with respect to drugs/medicines, now and in the future.
OBJECTIVES: A part of the research project mapping public beliefs about medicines aimed at getting the public to discuss definitions of drugs/medicines to grasp their explicit and implicit definitions and understand their point of reference when using the term(s).
METHODS: Eight focus groups were conducted in urban and rural Iceland, with 42 participants of both genders and varying age, a fifty-fifty mix of lay and educated groups. The interviews were transcribed verbatim and excerpts translated into English.
RESULTS: The direct question about definition of drugs generally resulted in a consensus among the informants about drugs/medicines being used to combat diseases and/or symptoms. Some included only prescribed or physician-recommended drugs in their definitions, others also over-the-counter products. Inclusion/exclusion of vitamins, food supplements, herbal remedies, functional foods, and illicit drugs was discussed without consensus and defining drugs in chemical terms or as interfering with bodily functions also occurred. New nuances emerged spontaneously later in the discussions, like viewing drugs as profit-making products, preferably prudently marketed, wishing information about "new release" drugs for the informants' diseases, and being concerned about side effects, overuse, misuse, and abuse. Other implicit definitions included viewing drugs as a product-service package, or as a necessary evil and/or as products with increasing potency and associated future problems or considering drugs to exert unreliable minor influence.
CONCLUSION: Professionals should be aware of the variety of lay people's drug definitions when discussing drugs/medicines with them to avoid misunderstandings caused by definition discrepancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19285288     DOI: 10.1016/j.sapharm.2008.04.003

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  4 in total

1.  An evaluation of consumers' perceptions regarding "modern medicines" in penang, malaysia.

Authors:  Zaheer-Ud-Din Babar; Mohamed Azmi Ahmad Hassali; Tai Lee Shyong; Tan Keat Hin; Chong Soon Cien; Lim Soo Bin; Shamini Chanmal Anantham; Ranita Kirubakaran; Sia Bee Ping; Ranita Kirubakaran; Chiew Shoen Chuen; Jaswinder Kaur Sohan Singh
Journal:  J Young Pharm       Date:  2012-04

2.  Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique study.

Authors:  Nyaradzo Mandimika; Karen I Barnes; Clare I R Chandler; Cheryl Pace; Elizabeth N Allen
Journal:  Malar J       Date:  2017-01-28       Impact factor: 2.979

3.  Over-the-counter medicine abuse - a review of the literature.

Authors:  Richard J Cooper
Journal:  J Subst Use       Date:  2011-10-03

4.  How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials.

Authors:  Elizabeth N Allen; Adiel K Mushi; Isolide S Massawe; Lasse S Vestergaard; Martha Lemnge; Sarah G Staedke; Ushma Mehta; Karen I Barnes; Clare I R Chandler
Journal:  BMC Med Res Methodol       Date:  2013-11-14       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.